HomeMIRM • NASDAQ
add
Mirum Pharmaceuticals Inc
Previous close
$44.06
Day range
$44.22 - $46.02
Year range
$23.14 - $54.23
Market cap
2.17B USD
Avg Volume
547.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 99.41M | 42.93% |
Operating expense | 100.86M | 30.78% |
Net income | -23.79M | 33.28% |
Net profit margin | -23.93 | 53.33% |
Earnings per share | -0.49 | 22.22% |
EBITDA | -18.17M | 32.94% |
Effective tax rate | 2.36% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 280.32M | -2.10% |
Total assets | 670.75M | 3.73% |
Total liabilities | 445.11M | 11.85% |
Total equity | 225.64M | — |
Shares outstanding | 49.01M | — |
Price to book | 9.43 | — |
Return on assets | -9.05% | — |
Return on capital | -11.08% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -23.79M | 33.28% |
Cash from operations | -5.07M | 69.50% |
Cash from investing | 641.00K | 132.05% |
Cash from financing | 5.34M | 200.51% |
Net change in cash | -466.00K | 97.22% |
Free cash flow | 3.00M | 116.56% |
About
Founded
2018
Headquarters
Website
Employees
322
